How the body responds to exercise at the cellular level

by Katharine Miller,Stanford UniversityGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2023.04.011Researchers have long been fascinated by the possibility that

Updated on: January 22,2024 25

How the body responds to exercise at the cellular level

by Katharine Miller,Stanford UniversityGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2023.04.011Researchers have long been fascinated by the possibility that

Updated on:January 22,2024 25

Ozempic May Help Treat Conditions Beyond Diabetes and Obesity

ByRachel MurphyFact checked byNick BlackmerKey TakeawaysThe active ingredient in Ozempic and Wegovy—semaglutide—is a powerful drug that might have more uses beyond treating typ

Updated on: April 01,2024 0

Ozempic May Help Treat Conditions Beyond Diabetes and Obesity

ByRachel MurphyFact checked byNick BlackmerKey TakeawaysThe active ingredient in Ozempic and Wegovy—semaglutide—is a powerful drug that might have more uses beyond treating typ

Updated on:April 01,2024 0

Tirzepatide associated with greater weight loss in women than men

byDiabetologiaCredit: Unsplash/CC0 Public DomainAll doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men,

Updated on: September 23,2024 0

Tirzepatide associated with greater weight loss in women than men

byDiabetologiaCredit: Unsplash/CC0 Public DomainAll doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men,

Updated on:September 23,2024 0

The side effects of 'andro,' the banned supplement androstenedione

by Steven ReinbergAndrostenedione is one of those supplements that was peddled to athletes for years as a quick path to bulging muscles and high testosterone levels, but it comes with some serious sid

Updated on: January 28,2024 20

The side effects of 'andro,' the banned supplement androstenedione

by Steven ReinbergAndrostenedione is one of those supplements that was peddled to athletes for years as a quick path to bulging muscles and high testosterone levels, but it comes with some serious sid

Updated on:January 28,2024 20

Study: Birth-control pills affect the body's ability to regulate stress

byAarhus UniversityMean concentrations of adrenocorticotropic hormone (ACTH) before and after 15 min of social interaction across the uterine cycle phases (menstrual, proliferative, and secretor

Updated on: January 22,2024 13

Study: Birth-control pills affect the body's ability to regulate stress

byAarhus UniversityMean concentrations of adrenocorticotropic hormone (ACTH) before and after 15 min of social interaction across the uterine cycle phases (menstrual, proliferative, and secretor

Updated on:January 22,2024 13

Weight management treatments increase weight loss in patients with obesity, finds study

by Elana GotkineFor patients with obesity, weight management treatments (WMTs) are associated with an increased probability of 5 percent or greater weight loss, according to astudypublishe

Updated on: March 21,2024 20

Weight management treatments increase weight loss in patients with obesity, finds study

by Elana GotkineFor patients with obesity, weight management treatments (WMTs) are associated with an increased probability of 5 percent or greater weight loss, according to astudypublishe

Updated on:March 21,2024 20

Tirzepatide versus Semaglutide in Weight Reduction

Clinical studies have demonstrated that both tirzepatide and semaglutide are effective in promoting weight loss among individuals with overweight or obesity.

Updated on: July 23,2024 0

Tirzepatide versus Semaglutide in Weight Reduction

Clinical studies have demonstrated that both tirzepatide and semaglutide are effective in promoting weight loss among individuals with overweight or obesity.

Updated on:July 23,2024 0

Abdominal obesity might predict risk of fecal incontinence

by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainFecal incontinence (FI), or involuntary loss of bowel control, significantly impacts quality of life and mental health for millions of a

Updated on: May 14,2024 0

Abdominal obesity might predict risk of fecal incontinence

by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainFecal incontinence (FI), or involuntary loss of bowel control, significantly impacts quality of life and mental health for millions of a

Updated on:May 14,2024 0

3-D microscopy clarifies understanding of body's immune response to obesity

by Lois Yoksoulian,University of Illinois at Urbana-ChampaignXiaohui Zhang, left, Andrew Smith, Kelly Swanson, Erik Nelson, Mark Anastasio and Junlong Geng are part of a team working to clarify

Updated on: April 02,2024 12

3-D microscopy clarifies understanding of body's immune response to obesity

by Lois Yoksoulian,University of Illinois at Urbana-ChampaignXiaohui Zhang, left, Andrew Smith, Kelly Swanson, Erik Nelson, Mark Anastasio and Junlong Geng are part of a team working to clarify

Updated on:April 02,2024 12

Diabetes drug may significantly lower women's risk of substantial weight gain after giving up smoking

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThe diabetes drug dulaglutide (Trulicity) may significantly lower a woman's risk of substantial weight gain after she has given up s

Updated on: December 28,2023 19

Diabetes drug may significantly lower women's risk of substantial weight gain after giving up smoking

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThe diabetes drug dulaglutide (Trulicity) may significantly lower a woman's risk of substantial weight gain after she has given up s

Updated on:December 28,2023 19

Zepbound bests Wegovy for weight loss in new trial

by Robin FosterZepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly."Given the increased interest a

Updated on: December 18,2024 0

Zepbound bests Wegovy for weight loss in new trial

by Robin FosterZepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly."Given the increased interest a

Updated on:December 18,2024 0

Doctors on front line of tackling childhood obesity need more training and resources, say researchers

by University of BirminghamCredit: Unsplash/CC0 Public DomainDoctors are feeling unable to tackle the growing problem of childhood obesity due to a lack of training and capacity according to new

Updated on: April 06,2024 0

Doctors on front line of tackling childhood obesity need more training and resources, say researchers

by University of BirminghamCredit: Unsplash/CC0 Public DomainDoctors are feeling unable to tackle the growing problem of childhood obesity due to a lack of training and capacity according to new

Updated on:April 06,2024 0